{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:13:37Z","timestamp":1794467617369,"version":"4.9.1"},"reference-count":0,"publisher":"Japan Medical Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMA J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.31662\/jmaj.2021-0019","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T02:02:11Z","timestamp":1626746531000},"page":"232-240","source":"Crossref","is-referenced-by-count":80,"title":["Antisense Oligonucleotide-Mediated Exon-skipping Therapies: Precision Medicine Spreading from Duchenne Muscular Dystrophy"],"prefix":"10.31662","volume":"4","member":"16605","container-title":["JMA Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmaj.jp\/download.php?id=10.31662\/jmaj.2021-0019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T02:02:19Z","timestamp":1626746539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmaj.jp\/detail.php?id=10.31662\/jmaj.2021-0019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":0,"journal-issue":{"issue":"3"},"alternative-id":["jmaj.2021-0019"],"URL":"https:\/\/doi.org\/10.31662\/jmaj.2021-0019","relation":{},"ISSN":["2433-3298","2433-328X"],"issn-type":[{"value":"2433-3298","type":"electronic"},{"value":"2433-328X","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}